SciSparc Ltd. — Major Shareholding Notification 2019

Feb 12, 2019

SC 13G/A 1 sc13ga.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G/A

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2(b)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)*

Therapix Biosciences Ltd.

(Name of Issuer)

American Depositary Shares (one of which represents 40 Ordinary Shares 1 , NIS 0.1 par value)

(Title of Class of Securities)

88339A 203 2

(CUSIP Number)

December 31, 2017

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the Rule pursuant to which this Schedule is filed:

| [ ] | Rule
13d – 1(b) |
| --- | --- |
| [X] | Rule
13d – 1(c) |
| [ ] | Rule
13d – 1(d) |

• The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1 Not for trading; one American Depositary Share represents 40 Ordinary Shares, NIS 0.1 par value.

2 This CUSIP number applies to the Issuer’s American Depositary Shares.

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 88339A 203

| 1. | NAME
OF REPORTING PERSON OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON John
Stetson | |
| --- | --- | --- |
| 2. | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP | |
| | (a) | [ ] |
| | (b) | [ ] |
| 3. | SEC
USE ONLY | |
| 4. | CITIZENSHIP
OR PLACE OF ORGANIZATION United States | |

| NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE
VOTING POWER 0 |
| --- | --- |
| 6. | SHARED
VOTING POWER 0 |
| 7. | SOLE
DISPOSITIVE POWER 0 |
| 8. | SHARED
DISPOSITIVE POWER 0 |

| 9. | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 |
| --- | --- |
| 10. | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] |
| 11. | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% |
| 12. | TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS) IN |

Field: Page; Sequence: 2; Options: NewSection; Value: 2

• 2 -

Field: /Page

CUSIP No. 88339A 203

| 1. | NAME
OF REPORTING PERSON OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON HS
Contrarian Investments, LLC | |
| --- | --- | --- |
| 2. | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP | |
| | (a) | [ ] |
| | (b) | [ ] |
| 3. | SEC
USE ONLY | |
| 4. | CITIZENSHIP
OR PLACE OF ORGANIZATION Florida | |

| NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE
VOTING POWER 0 |
| --- | --- |
| 6. | SHARED
VOTING POWER 0 |
| 7. | SOLE
DISPOSITIVE POWER 0 |
| 8. | SHARED
DISPOSITIVE POWER 0 |

| 9. | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 |
| --- | --- |
| 10. | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] |
| 11. | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% |
| 12. | TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS) CO |

Field: Page; Sequence: 3; Value: 2

• 3 -

Field: /Page

CUSIP No. 88339A 203

| 1. | NAME
OF REPORTING PERSON OR I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON Stetson
Capital Investments, Inc. | |
| --- | --- | --- |
| 2. | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP | |
| | (a) | [ ] |
| | (b) | [ ] |
| 3. | SEC
USE ONLY | |
| 4. | CITIZENSHIP
OR PLACE OF ORGANIZATION Florida | |

| NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE
VOTING POWER 0 |
| --- | --- |
| 6. | SHARED
VOTING POWER 0 |
| 7. | SOLE
DISPOSITIVE POWER 0 |
| 8. | SHARED
DISPOSITIVE POWER 0 |

| 9. | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 |
| --- | --- |
| 10. | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] |
| 11. | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% |
| 12. | TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS) OO |

Field: Page; Sequence: 4; Value: 2

• 4 -

Field: /Page

| Item
1(a). | Name
of Issuer: |
| --- | --- |
| | THERAPIX
BIOSCIENCES LTD. (the “Issuer”) |
| Item
1(b). | Address
of Issuer’s Principal Executive Offices: |
| | 4
Ariel Sharon Street, HaShahar Tower, 16th Floor, Givatayim 5320047, Israel |
| Item
2(a). | Name
of Person Filing. |
| | The
statement is filed on behalf of John Stetson, HS Contrarian Investments, LLC (“HSCI”) and Stetson Capital Investments,
Inc. (“SCI”) (collectively, the “Reporting Persons”). John Stetson is the Managing Member of HSCI
and in such capacity has voting and dispositive power over the securities held by such entity. John Stetson is the President
of SCI and in such capacity has voting and dispositive power over the securities held by such entity. |
| Item
2(b). | Address
of Principal Business Office or, if None, Residence. |
| | 2300
E. Las Olas Blvd. 4 th Floor, Fort Lauderdale, FL 33301 |
| Item
2(c). | Citizenship. |
| | John
Stetson is a citizen of the United States. HSCI and SCI are each organized in the state of Florida. |
| Item
2(d). | Title
of Class of Securities. |
| | American
depositary shares (one of which represents 40 ordinary shares, NIS 0.1 par value) |
| Item
2(e). | CUSIP
Number. |
| | 88339A
203 (This CUSIP number applies to the Issuer’s American Depositary Shares.) |
| Item
3. | Type
of Person. |
| | Not
applicable. |
| Item
4. | Ownership. |
| | The
information required by Items 4(a) – (c) is set forth in Rows (5) – (11)
of the cover page for each of the Reporting Persons hereto and is incorporated herein
by reference for the Reporting Persons. The information set forth in Rows (5) –
(11) of the cover page for each of the Reporting Persons hereto is made as of December
31, 2018. |

Field: Page; Sequence: 5; Value: 2

• 5 -

Field: /Page

| Item
5. | Ownership
of Five Percent or Less of a Class. |
| --- | --- |
| | If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following [X]. |
| Item
6. | Ownership
of More than Five Percent on Behalf of Another Person. |
| | Not
applicable. |
| Item
7. | Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company. |
| | Not
applicable. |
| Item
8. | Identification
and Classification of Members of the Group. |
| | Not
applicable. |
| Item
9. | Notice
of Dissolution of Group. |
| | Not
applicable. |
| Item
10. | Certifications. |
| | By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |

Field: Page; Sequence: 6; Value: 2

• 6 -

Field: /Page

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

| February
12, 2019 |
| --- |
| Date |
| /s/ John
Stetson |
| Signature |
| HS
CONTRARIAN INVESTMENTS, LLC |
| /s/John
Stetson |
| Signature |
| John
Stetson, Managing Member |
| Name/Title |
| STETSON
CAPITAL INVESTMENTS, INC. |
| /s/John
Stetson |
| Signature |
| John
Stetson, President |
| Name/Title |

Field: Page; Sequence: 7; Value: 2

• 7 -

Field: /Page